The Future of Onco-Cardiology: We Are Not Just "Side Effect Hunters".
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27688305.
- Also identified by DOI 10.1161/CIRCRESAHA.116.309573 and PMC identifier 5147506.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cancer treatments in general share various detrimental effects in common, especially upregulation of cardiovascular risk factors. Therefore, the science of onco-cardiology should not be restricted in scope to the side effects of each specific cancer drug. In particular, premature aging induced by cancer treatment may contribute to the chronic health problems of cancer survivors.
Medical subject headings
- Antineoplastic Agents
- Cardiology
- Cardiotoxicity
- Cardiovascular Diseases
- Medical Oncology
- Neoplasms